Evidence map›Paper›PMID 39417194›Full record

ReviewAmerican journal of cancer research2024

Research progress on machine algorithm prediction of liver cancer prognosis after intervention therapy.

Feng Guo, Hao Hu, Hao Peng, Jia Liu, Chengbo Tang, Hao Zhang

Abstract readReview
In one paragraph

Review in American journal of cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feng GuoDepartment of Interventional Diagnosis and Treatment, Yongzhou Central Hospital, Yongzhou Clinical College, University of South China Yongzhou 425000, Hunan, China.
Hao HuDepartment of Gynecologic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430079, Hubei, China.
Hao PengDepartment of Abdominal Oncology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture Enshi 445000, Hubei, China.
Jia LiuDepartment of Oncology, The First People's Hospital of Changde City Changde 415003, Hunan, China.
Chengbo TangDepartment of Interventional Diagnosis and Treatment, Yongzhou Central Hospital, Yongzhou Clinical College, University of South China Yongzhou 425000, Hunan, China.
Hao ZhangDepartment of Interventional Vascular Surgery, First Affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital) Changsha 410000, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment for liver cancer has transitioned from traditional surgical resection to interventional therapies, which have become increasingly popular among patients due to their minimally invasive nature and significant local efficacy. However, with advancements in treatment technologies, accurately assessing patient response and predicting long-term survival has become a crucial research topic. Over the past decade, machine algorithms have made remarkable progress in the medical field, particularly in hepatology and prognosis studies of hepatocellular carcinoma (HCC). Machine algorithms, including deep learning and machine learning, can identify prognostic patterns and trends by analyzing vast amounts of clinical data. Despite significant advancements, several issues remain unresolved in the prognosis prediction of liver cancer using machine algorithms. Key challenges and main controversies include effectively integrating multi-source clinical data to improve prediction accuracy, addressing data privacy and ethical concerns, and enhancing the transparency and interpretability of machine algorithm decision-making processes. This paper aims to systematically review and analyze the current applications and potential of machine algorithms in predicting the prognosis of patients undergoing interventional therapy for liver cancer, providing theoretical and empirical support for future research and clinical practice.

Indexed as

interventional therapyliver cancerMachine algorithmsprognosis prediction

Identifiers

PMID39417194
PMCPMC11477842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.